Abbreviated New Drug Application Claim
An Abbreviated New Drug Application (ANDA) Claim arises when there is a dispute or legal challenge related to the submission or approval of an ANDA, which allows for the marketing of a generic drug that demonstrates bioequivalence to an already approved brand-name drug. This claim can involve issues of patent infringement, exclusivity rights, or regulatory compliance.
Also known as
ANDA Claim, ANDA Dispute Claim, Bioequivalence Application Claim, Generic Drug Application Claim, Generic Medicine Application Claim
Ancestry paths
- Objectives Litigation Objectives Litigation Claims Civil Claims Statutory and Regulatory Claims
- Objectives Litigation Objectives Litigation Claims Statutory and Regulatory Claims
- Objectives Litigation Objectives Litigation Claims Civil Claims Intellectual Property Claims
- Objectives Litigation Objectives Litigation Claims Civil Claims Business Torts and Actions Intellectual Property Claims
- +1 more paths
Generated from sali-legal/LMSS at 3f9ac0c9357b (2026-03-10). JSON